Track the Park Dental Partners, Inc. stock price and the full insider trade history of the company, a publicly traded company based in United States. Shares are quoted on US US, under the authority of SEC (Form 4). Operating in the Healthcare & Pharma sector, Park Dental Partners, Inc. has published 2 insider filings. Market capitalisation: €81.9m. The latest transaction was disclosed on 5 December 2025 (Acquisition). Among the most active insiders: SWENSON PETER G. The full history is accessible without an account.
Analysts rate Park Dental Partners, Inc. Strong Buy (bullish), based on 2 analysts. Average price target: US$22.75.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
2 of 2 declarations
Park Dental Partners, Inc. (NASDAQ: PARK) is a United States-based dental services platform structured as a dental resource organization (DRO). Headquartered in Roseville, Minnesota, the company provides comprehensive non-clinical support to affiliated general and multi-specialty dental practices. Its service model includes clinical team members, administrative personnel, facilities, equipment, technology, and centralized operational support. For investors, the business is best understood as a dental network enabler rather than a traditional single-site provider: Park Dental Partners helps affiliated practices run efficiently while clinicians focus on patient care. The company traces its operating heritage back to 1972, when its general dentistry group was established. Park Dental Partners also highlights a long-standing commitment to quality and clinical standards, including an accreditation milestone achieved in 1979 by what is now the Accreditation Association for Ambulatory Health Care. The current corporate structure was formalized in 2023, building on decades of collaboration between Park Dental and The Dental Specialists. That history matters strategically, because it suggests that Park Dental Partners entered public markets with an established operating base rather than as a newly created roll-up. Its core business is the support of affiliated dental practices across a broad set of services. The company’s network offers general dentistry as well as specialty care such as oral surgery, periodontics, pediatric dentistry, prosthodontics, endodontics, and orthodontics. This multi-specialty footprint is important competitively: it supports patient retention, broadens the service mix, and allows the company to leverage shared infrastructure across practices. The model also creates operating leverage when new clinics or specialists are added to the network. Geographically, the business is primarily concentrated in Minnesota and Wisconsin, with expansion beyond its historical core now visible in Arizona. Recent company communications indicate a network supporting more than 200 dentists across roughly 85 to 88 practice locations in three states, along with a large clinical support workforce. That regional concentration gives the company meaningful density in core markets, while also exposing it to local reimbursement, labor, and competitive dynamics. Recent developments are notable. Park Dental Partners began trading on The Nasdaq Capital Market on December 3, 2025, following its initial public offering. In early 2026, management reported full-year 2025 results, including revenue growth, new acquisitions in Minnesota and Arizona, and the opening of a de novo multi-specialty practice in Rochester, Minnesota. The company also highlighted additional affiliations and rebranding activity across its platform. For investors, the near-term story is centered on disciplined expansion, integration of new practices, and execution in a service-intensive healthcare niche. Within the Health & Pharma sector in the United States, PARK is a relatively recent listed name, but one with a long operating history and a clearly defined consolidation strategy.